Qiao-ling Zheng
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping: Chemotherapy, Immunotherapy, or Targeted Therapy?-A Retrospective Analysis.
Journal: Annals of surgical oncology
Published: April 03, 2025
Intratumoral plasma cells predict patient prognosis and responsiveness to neoadjuvant immunotherapy in advanced gastric cancer.
Journal: NPJ precision oncology
Published: February 12, 2025
Enhancing gastric cancer immunotherapy: Insights from multi-omics analysis and innovations in photodynamic-chemotherapy nanoplatforms.
Journal: Cell reports. Medicine
Published: November 06, 2024
Loss of ATOH1 in Pit Cell Drives Stemness and Progression of Gastric Adenocarcinoma by Activating AKT/mTOR Signaling through GAS1.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 29, 2023
Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 14, 2022
Indocyanine green fluorescence imaging-guided versus conventional laparoscopic lymphadenectomy for gastric cancer: long-term outcomes of a phase 3 randomised clinical trial.
Journal: Nature communications
Published: December 02, 2022
m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer.
Journal: Cell death & disease
Published: November 01, 2021
An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer.
Journal: Nature communications
Published: February 22, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026